Revolade is indicated for the treatment of previously treated patients aged 6 years and above with chronic idiopathic thrombocytopenic purpura (ITP) to increase platelet count and reduce or prevent bleeding.

Revolade is indicated for the treatment of thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.

Revolade is indicated for the treatment of adult patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.

 

×

Medical Information Request

×

Ask Speakers